MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 10 analysts with an average price target of $9.13. This is a potential upside of $5.6 (158.64%) from yesterday's end of day stock price of $3.53.

Mersana Therapeutics's activity chart (see below) currently has 30 price targets and 39 ratings on display. The stock rating distribution of MRSN is 70% BUY and 30% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.78% with an average time for these price targets to be met of 248.92 days.

Highest price target for MRSN is $9, Lowest price target is $1, average price target is $9.13.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 29-Feb-2024. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 14 are a BUY (70%), 6 are a HOLD (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$3.47 (98.30%)

2

2 months 9 days ago

3/6 (50%)

$1.56 (28.68%)

191

Buy

9

$5.47 (154.96%)

2 months 9 days ago

0/2 (0%)

$3.56 (65.44%)

Buy

7

$3.47 (98.30%)

14

2 months 9 days ago

1/3 (33.33%)

$1.56 (28.68%)

1072

Hold

1

$-2.53 (-71.67%)

10

9 months 10 days ago

0/3 (0%)

$-0.26 (-20.63%)

Hold

5

9 months 11 days ago

2/3 (66.67%)

$1.46 (19.97%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 248.92 days on average for the stock forecasts to be realized with a an average price target met ratio 32.78

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 2 price targets and 2 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Michael Ulz with highest potential upside - $25.74

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Ashik Kurian with lowest potential downside - -$2.53

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?